| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $3.12 | $3.35 | $3.36 | $3.14 | $2.25 | $1.27 | $1.11 | $0.93 |
| EPS (Diluted) | $3.06 | $3.26 | $3.27 | $3.01 | $2.16 | $1.24 | $1.08 | $0.91 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.7B | $4.1B | $3.8B | $3.1B | $2.6B | $1.8B | $1.1B | $1.0B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $4.3B | $3.7B | $3.5B | $2.9B | $2.4B | $1.6B | $1.0B | $0.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.5B | $0.4B | $0.3B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.3B | $0.2B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B |
| Investing Cash Flow | $-0.5B | $-0.6B | $-0.6B | $-1.0B | $-0.9B | $-0.7B | $-0.2B | $-0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.6B | $0.3B | $0.5B | $0.4B | $0.9B | $0.6B | $0.2B | $0.1B |